Form 4: Waters Corp Grants Equity to SVP Carpio

Waters Corporation's SVP Robert L. Carpio III received grants of restricted stock units and stock options as part of his compensation.

Summary

• Robert L. Carpio III, SVP Waters Analytical Sciences at Waters Corporation (WAT), was granted equity awards.
• He acquired 997 restricted stock units (RSUs) on February 25, 2026.
• These RSUs will vest in four equal annual installments, with the first vesting on February 25, 2027, contingent on continued service.
• The RSUs are convertible into common stock on a one-to-one basis upon vesting.
• He also acquired 4,884 stock options on February 25, 2026, with an exercise price of $319.44.
• These stock options will vest and become exercisable in four equal annual installments, with the first vesting on February 25, 2027, also contingent on continued service.
• The stock options have an expiration date of February 25, 2036.
• Following these transactions, Carpio beneficially owns 3,615 shares of common stock directly and 4,884 derivative securities (stock options) directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation practices aimed at retaining key talent and aligning management incentives with long-term shareholder value.

Positives

• The grants serve as a long-term incentive for a key executive, aligning his interests with shareholder value.
• Equity compensation helps retain senior talent within the company.

Negatives

• The issuance of new equity awards could lead to minor dilution for existing shareholders over time as RSUs vest and options are exercised.

Future Outlook

The grants are structured with multi-year vesting schedules, indicating a long-term commitment to the executive and a focus on future performance. The first vesting for both RSUs and stock options is scheduled for February 25, 2027, with subsequent installments annually thereafter.

Industry Context

StockSavvy.ai notes that equity grants to senior executives like Robert L. Carpio III are a standard practice across the life sciences and analytical instrumentation industry. Such compensation structures are designed to incentivize long-term performance and align executive interests with shareholder returns, a common strategy for talent retention in competitive sectors.

Comparison to Industry Standards

• Equity compensation packages, including RSUs and stock options with multi-year vesting, are standard practice for senior executives in the technology and life sciences sectors.
• For example, companies like Thermo Fisher Scientific (TMO) and Agilent Technologies (A) frequently utilize similar long-term incentive plans to retain key talent and drive strategic objectives.
• The vesting schedule of four equal annual installments is typical for such grants, ensuring sustained commitment from the executive.

Related Party Transactions

• The grants of restricted stock units and stock options to Robert L. Carpio III, a Senior Vice President, constitute transactions with a related party (an officer of the company).

Stakeholder Impact

• Shareholders: Potential minor dilution over time as RSUs vest and options are exercised, but also benefit from incentivized executive performance.
• Employees: Standard executive compensation practices can signal stability and a clear incentive structure within the company.

Next Steps

• Continued service by Robert L. Carpio III to meet vesting conditions for RSUs and stock options.
• Annual vesting of RSUs and stock options, with the first installment on February 25, 2027.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a senior executive, which is a standard part of compensation and retention strategies. It does not present new information that would fundamentally alter the investment thesis for Waters Corporation, hence a 'hold' recommendation is appropriate as it reflects normal business operations without significant positive or negative catalysts.

Keywords

Waters Corporation, WAT, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSUs, Stock Options, Executive Compensation, Robert L. Carpio III, SVP Waters Analytical Sciences